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Background: Cardiac risk scores estimate a patient’s risk of future cardiac events or death. They are developed to
inform treatment decisions of patients diagnosed with unstable angina or non-ST-elevation myocardial infarction.
Despite recommending their use in guidelines and evidence of their prognostic value, they seem underused in
practice. The purpose of the study was to gain insight in the motivation for implementing cardiac risk scores, and
perceptions of health care practitioners towards the use of these instruments in clinical practice.
Methods: This qualitative study involved semi-structured interviews with 31 health care practitioners at 11 hospitals
throughout the Netherlands. Participants were approached through purposive sampling to represent a broad range
of participant- and hospital characteristics, and included cardiologists, medical residents, medical interns, nurse
practitioners and an emergency physician. The Pettigrew and Whipp Framework for strategic change was used as a
theoretical basis. Data were initially analysed through open coding to avoid forcing data into categories
predetermined by the framework.
Results: Cardiac risk score use was dependent on several factors, including IT support, clinical relevance for daily
practice, rotation of staff and workload. Both intrinsic and extrinsic drivers for implementation were identified.
Reminders, feedback and IT solutions were strategies used to improve and sustain the use of these instruments.
The scores were seen as valuable support systems in improving uniformity in treatment practices, educating interns,
conducting research and quantifying a practitioner’s own risk assessment. However, health care practitioners varied
in their perceptions regarding the influence of cardiac risk scores on treatment decisions.
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Conclusions: Health care practitioners disagree on the value of cardiac risk scores for clinical practice. Practitioners
driven by intrinsic motivations predominantly experienced benefits in policy-making, education and research.
Practitioners who were forced to use cardiac risk scores were less likely to take into account the risk score in their
treatment decisions. The results of this study can be used to develop strategies that stimulate or sustain cardiac risk
score use in practice, while taking into account barriers that affect cardiac risk score use, and possibly reduce practice
variation in the management of unstable angina and non-ST-elevation myocardial infarction patients.
Keywords: Risk assessment, Acute coronary syndromes, Guideline adherence, ImplementationBackground
Cardiovascular diseases, including unstable angina (UA)
and non-ST-elevation myocardial infarction (NSTEMI),
are among the main causes of death of people across the
world [1,2]. International guidelines for the management
of UA and NSTEMI [3-5] recommend to treat patients on
the basis of their risk for adverse cardiac events such as re-
infarction or death. High risk patients can be successfully
treated with invasive procedures such as Percutaneous Cor-
onary Intervention (PCI) or Coronary Artery Bypass Graft-
ing (CABG). To accomplish this and to guide physicians in
tailored therapeutic decision-making, several cardiac risk
stratification scores have been developed [3,5], i.e. the
GRACE- [6,7], TIMI- [8], PURSUIT- [9], FRISC- [10], and
HEART [11] scores. Cardiac risk scores comprise of clinical
factors associated with adverse cardiac outcomes [12]. The
validity of these instruments in terms of their ability to
predict the patient’s risk of re-infarction or death during
hospitalization or after discharge was reported to be good
[10,11,13-15]. Previous studies indicate that risk assessment
based on physician’s experience was inferior compared to
risk assessment by using validated risk scores [14,16]. How-
ever, despite guideline recommendations and their prog-
nostic value, these instruments are not widely adopted in
clinical practice [17]. Practitioner related barriers e.g. know-
ledge, attitude, behavior, and external barriers related to the
guideline, patient or organization, all affect guideline adher-
ence by physicians [18]. Several studies reported low guide-
line adherence among physicians when managing UA/
NSTEMI patients, resulting in a treatment risk paradox i.e.
patients with a low risk of re-infarction or death were more
likely to receive invasive treatment strategies (e.g. angiog-
raphy and/or revascularization) compared to high risk pa-
tients [19-26]. Therefore, a gap between evidence-based
care and routine clinical practice may exist which could
affect patient outcomes negatively [21,27-29]. To improve
guideline adherence, quality improvement programs have
been initiated in several countries [30-33]. Recently in the
Netherlands, such a program was introduced in which,
among other things, the use of cardiac risk scores was eval-
uated [34]. However, to our knowledge, it is unknown to
what degree healthcare professionals’ perceptions regardingthe value of cardiac risk scores in therapeutic decision mak-
ing may affect the use of these scores in clinical practice.
There is also little understanding of factors that facilitate or
hinder health care practitioners in their attempts to imple-
ment these risk scores in practice. Therefore the objectives
of the study are to gain insight in the motivation for imple-
menting cardiac risk scores, and perceptions of health care
practitioners towards the use of these instruments in
clinical practice.
Methods
Study design and setting
A qualitative study involving semi-structured interviews
was conducted. Professionals employed at cardiology
departments of hospitals that previously participated in
the evaluation of a Dutch quality improvement program
(n = 13), were approached for participation in this study.
This program aimed to optimize care for patients diag-
nosed with acute coronary syndromes, including UA and
NSTEMI, and is based on the recommendations of the
European Society of Cardiology guidelines. The hospital
sample was verified to be representative for the Dutch
population of hospitals, with regard to type of hospital,
e.g. teaching versus non-teaching, and the availability of
specific cardiac facilities, e.g. PCI or CABG.
Study participants
In each hospital, the cardiologist who was a contact
person for the Dutch quality improvement program was
approached for participation in the present study. They
were selected because they were involved in implementing
a cardiac risk score in their institution. After each inter-
view they were asked to recruit or provide contact details
of a colleague within their department. They were subse-
quently approached directly by the researcher (JE) during
site visits or by email. Participants were eligible if they
were a) currently employed in one of the participating
hospitals, b) directly involved in the treatment of UA/
NSTEMI patients, i.e. physicians or nurses, c) regardless
of their attitude/opinion were experienced in using cardiac
risk scores and/or d) involved in the implementation of a
cardiac risk score. By means of purposive sampling, the
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profession, their level of work experience and the type of
hospital they worked in.
Development of interview protocol
The interview protocol was structured according to the
three dimensions of the Pettigrew and Whipp framework
i.e. context, process and content [35] and by reviewing lit-
erature about implementation strategies and correspond-
ing barriers and facilitators (Additional file 1) [36-39]. For
the present study, the three dimensions of the framework
were interpreted as following: context; what are motiva-
tions behind the use of cardiac risk scores?, process; what
strategies are applied to enable, enhance and/or sustain
cardiac risk score use and which factors influence this
process?, content; what are opinions of health care practi-
tioners towards the value of cardiac risk scores for clinical
practice and which effects did they perceive? The inter-
view protocol was pilot-tested with an emergency phys-
ician who was involved in the implementation of a cardiac
risk score, but was not part of the current research sam-
ple. In addition, the adequacy and functionality of the re-
vised interview protocol was discussed within the research
team until consensus was reached.
Data collection
Semi-structured interviews were conducted between
September 2012 and May 2013. Data were collected on
site or at the participant’s home. Prior to the interview,
participants received an information letter explaining de-
tails about the study. All interviews were audio-recorded
and transcribed at verbatim unless participants objected.
In the latter case, hand written notes were made and a
detailed transcription was sent back to the participant
for verification (n = 1). Interviews were conducted by
one member of the research team (JE) who was trained
in qualitative interviewing.
Qualitative data analysis
The transcribed interviews were initially analyzed using
open coding to avoid forcing data into the predeter-
mined categories i.e. context, content and process. The
first five transcribed interviews were coded by two re-
searchers independently, to form an initial code list and
to enhance reliability of the analyses process (JE, MJH).
Differences between the coding’s of the researchers were
resolved in consensus meetings. During the analyses of
subsequent interviews, the initial code list was further
refined by adding new codes or reconstructing existing
codes. The definitions of the final code set and the
hierarchy of the code structure were reviewed for logic.
The final version of the code structure was applied on
all transcribed interviews (JE). To ensure concordance
in codings, 50% of the transcriptions were codedindependently by a second researcher (MJH). Relevant
differences in applying the final code structure were
discussed and resolved. All transcriptions were reviewed
with the revised final code structure by one researcher
(JE). To determine if the code structure was sufficient
and to ensure no new information occurred (i.e. satur-
ation), three additional interviews were subsequently
conducted, transcribed and analyzed [40]. All data were
analyzed in Atlas.ti V.5.7 (ATLAS.ti Scientific Software
Development Company, GmbH, Berlin, Germany).
Validation and reliability
Several techniques were used to enable a systematic and
transparent process of data collection and analyses.
First, after each interview field notes were made which
included factual data regarding the interview-setting,
observations during the interview, and reflective infor-
mation regarding thoughts and concerns. They were
used to interpret the data more carefully. Second, the
interview protocol was consistently used and critically
reviewed after each interview. Third, two researchers
coded the transcribed interviews independently in
ATLAS.ti to manage the coding process. Finally, con-
sensus meetings were held to discuss and reconcile
differences in coding of the data. Analytical decisions
made in the consensus meetings were documented.
Ethics
Ethics approval was obtained from the medical ethical
committee of the VU University Medical Center
Amsterdam. Written informed consent for participation
and audio-taping of the interview was obtained from all
respondents. Confidentiality was assured by removing
traceable information from transcripts relating to par-
ticipating hospital sites or individuals. Data were stored
on a protected network server at the research institute,
only accessible to the research team.
Results
Interviews were conducted at 11 hospitals. Two teaching
hospitals with invasive treatment facilities on site refused
to participate. One hospital considered interviews too
much of a burden for staff, the other hospital did not
provide a reason for refusal. In total 37 health care pro-
fessionals were approached, of which 16 cardiologists,
seven medical residents, four medical interns (including
one research fellow), three nurse specialists and one
emergency physician, were interviewed (Table 1). They
were familiar with either the GRACE-, TIMI-, FRISC- or
HEART risk score at their institution. Six participants
could not be interviewed, due to among other a lack of
time, resignation or long term absence (Figure 1). The
average length of an interview was approximately 30 mi-
nutes, however, substantial variations in length occurred.
Table 1 Hospital and participant characteristics







PCI and CABG 3 (27.3)
No revascularization facilities 6 (54.5)





Mean (SD)/Range 38.9 (9.4)/26-61









Medical intern 4 (12.9)
< 5 3 (75)
5-10 1 (25)
> 10 n.a.
Nurse specialist 3 (9.7)
< 5 1 (33.3)
5-10 2 (66.7)
> 10 n.a.




Length of interview (minutes)
Median (IQR) 28.2 (25.6)





aIn no. (%), unless stated otherwise; bYears in current profession/position.
Abbreviations: PCI, percutaneous coronary intervention; CABG, coronary artery
bypass grafting; n.a., not applicable.
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dimensions of the Pettigrew and Whipp Framework
(Table 2). These are elaborated below and illustrated by
representing quotations (Additional file 2: Table S3).
I Stimuli for implementing cardiac risk scores (context)
Two types of stimuli to implement cardiac risk scores
were reported by participants: intrinsic motivations i.e.
from within the department and extrinsic motivations i.e.
external pressure. In most cases both factors were drivers
for cardiology departments to implement a cardiac risk
score instrument.
Intrinsic motivations
The need for a more uniform approach in admission
and treatment practices for patients presenting with sus-
pected UA or NSTEMI was the most commonly men-
tioned motivation for implementing a cardiac risk score.
Also, educational purposes were a frequently mentioned
motivation. It was expected that the use of cardiac risk
scores created awareness among less experienced physi-
cians in estimating patients’ risk of re-infarction or
death. Finally, cardiac risk scores were considered of
value for scientific research in which they were used to
determine the characteristics of the patient population.
Extrinsic motivations
External pressures such as the incorporation of cardiac
risk score use in European Society of Cardiology guide-
lines accelerated the implementation process in several
hospitals. In addition, a national quality improvement
program stimulated the use of these guidelines and,
partly due to its obligatory character, all hospitals aimed
to follow these recommendations. Some participants ex-
perienced additional pressure from their hospital board
to comply with the requirements of the quality improve-
ment program. Other less frequently mentioned pres-
sures were recommendations of the Dutch Association
of Cardiology, regulatory audits from the health care
inspectorate, and performance assessments by health
care insurance companies.
II Process of implementing cardiac risk scores (process)
Participants mentioned three complementary categories,
which determine the process of implementation: implemen-
tation strategies, barriers and facilitators and sustainability.
Implementation strategies
Support of senior staff was considered effective in enhancing
the implementation and was accomplished by actively refer-
ring to cardiac risk scores e.g. during hand-off sessions.
Written reminders to the entire team were applied to pay at-
tention to non-compliance. Also, individuals were personally
addressed by one of the senior staff members. Several
Included 
n = 11 
Reasons for non-response (n = 2): 
- Too high burden for staff (1) 
- Unknown/not interested (1)
Approached 
participants 
n = 37 
Eligible if: 
- Employed in one of the participating hospitals; 
- Involved in the treatment of UA/NSTEMI patients; 
- Experienced in application of cardiac risk scores; 
- Involved in implementation of cardiac risk scores. 
Reasons for non-response (n = 6): 
- A lack of time (1) 
- Resignation (1)
- Long term absence (2)
- Unknown (2)
Eligible hospitals 
n = 13 
Included 
n = 31 
Eligible if: 
- Hospital participated in the evaluation of the 
theme ‘optimal care for acute coronary 
syndromes’ of the national quality improvement 
program. 
Figure 1 Flow diagram of hospital and participant selection.
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ate colleagues. To build a consistent knowledge base among
medical residents and interns, in all hospitals lectures and
personal or written instructions were provided. Finally, other
incidentally mentioned interventions, as part of the imple-
mentation strategy, were: developing a project plan, establish
a working committee and the use of passive reminders, e.g.
posters.Facilitators and barriers
Respondents mentioned that resistance in applying car-
diac risk scores was related to the absence of a clinical
consequence or critics against the available scientific evi-
dence for using these instruments. Stressing the clinical
relevance and importance, especially by the senior staff,
was therefore considered crucial in reducing resistance.
Also the administrative burden and complexity of risk
Table 2 Themes, categories and concepts
PGF dimensionsab Category Description Concepts
WHY context Intrinsic
motivations
Personal beliefs of health care











pressure that leads to the
implementation
(Inter) national guideline recommendations
Governmental pressure and regulatory demands: quality
improvement program, recommendations of Dutch association of
cardiology, audits of health care inspectorate
Pressure hospital board
Assessments by health care insurance companies
HOW process Implementation
strategies
Interventions used to enhance or
support the implementation process




Clinical reminders: posters (passive), written and oral reminders
(active)
Data feedback





Influential factors enhancing or
hindering the implementation process
Facilitating factors
Innovation level: clinical relevance
Practitioner level: commitment staff
Organization level: management support, IT support
Barriers
Innovation level: administrative burden, complexity of underlying
algorithm of risk score, loss of time
Practitioner level: level of work experience, familiarization with
new practices, lack of knowledge, lack of relevance
Organization level: frequent staff rotation, high work load, lack of
time, lack of management priority, lack of resources, fast update
of guidelines, unexpected circumstances
Sustainability Interventions undertaken to sustain
change in practices
Redesigning systems: integration of risk score(s) in existing
electronic hospital systems, protocols or clinical pathways
Audit and feedback
Appointment of champions
WHAT content Choice of risk
score
Motivation for implementing cardiac risk
score and its use in practice
Choice of risk score based on: purpose, availability relevant
parameters, complexity, validity and available scientific evidence,





Use in practice: type of risk score (GRACE, TIMI, FRISC or HEART),
intended users (interns, residents, less often cardiologist, nurse
specialists), target group (patients with chest pain, unstable
angina, non-ST-elevation myocardial infarction or acute coronary





Implementation effects in terms of
benefits and risks for quality and safety
of care
Expected benefits: improved uniformity, educational support,
scientific benefits





Impact on physician’s decision-making
process in terms of admission and treat-
ment policies
Treatment policy: no consequence, conservative treatments
(pharmacological), invasive treatments (cardiac catheterization or
revascularization)
Admission policy: admission protocol, patient allocation, patient
flow
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Table 2 Themes, categories and concepts (Continued)
Effects on
process of care
Effectiveness of cardiac risk score
implementation
Current practice and variation in practice
aPettigrew & Whipp framework. bThe provided information cuts across more than one dimension.
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was solved by support from the hospital management
board and information technology (IT) department by
integrating the calculation and registration of cardiac
risk scores in existing software platforms. However, for
some risk scores the underlying algorithms were not
directly accessible which delayed IT integration.
In explaining low compliance rates, several respon-
dents mentioned that the value of a cardiac risk score in
practice was dependent of the professional’s experience
in cardiology. For example, medical interns were fre-
quently mentioned as benefitting most from using a risk
score in founding their treatment decisions in contrast
to experienced cardiologists. Moreover, participants no-
ticed that less experienced cardiologists were generally
more familiar with clinical prediction models compared
to the older. The latter group familiarized themselves
more slowly with a cardiac risk scoring instrument.
Another barrier in implementing cardiac risk scores was
the frequent rotation of medical interns. Continuous
education and reminders were necessary to support and
sustain the use of cardiac risk scores. Also a high-
workload and a lack of available time were frequently
mentioned as hindering factors in the application of the
risk score. Some cardiologists expressed that external
pressures, such as audits, were necessary to be given
priority and to receive support of the hospital manage-
ment board. Other less frequently experienced barriers
were a lack of available resources including finances and
personnel, lack of relevance (e.g. absence of on-site
revascularization options or number of employed cardi-
ology residents), frequent updates of the guidelines and
unexpected circumstances including the absence of key
persons due to sick leave.Sustainability
Although most hospitals were in the process of integrating
cardiac risk scores in clinical practice, specific strategies
were applied to maintain its use on the long term. IT
solutions to incorporate cardiac risk scores in the hospital
system, including triggers, links and mandatory fields, were
helpful reminders. Hospitals without such facilities inte-
grated the cardiac risk score in existing clinical pathways or
protocols. Another strategy to maintain cardiac risk score
use was periodic audit and feedback sessions. Finally, in
some hospitals champions, e.g. a nurse specialist or re-
search fellow, supported by a cardiologist monitored the
implementation.III Perceptions of health care practitioners (content)
Perceptions of health care practitioners regarding cardiac
risk scores and their use could be allocated in four
categories: choice of risk score, unintended and intended
benefits and risks, impact on treatment policies, and effects
on the process of care.Choice of risk score
Hospitals aimed to apply cardiac risk scores when
patients presented at the emergency department, chest
pain unit or the coronary care unit with a suspected or
confirmed diagnosis of UA or NSTEMI. Aspects deter-
mining the choice for a specific cardiac risk scoring in-
strument were the purpose of the risk score, availability
of the parameters necessary to determine patients’ risk,
guideline recommendations and scientific evidence.
Most hospitals implemented the GRACE risk score.
However, applicability of the GRACE was limited due to
its dependency on calculators and IT solutions. Some
hospitals therefore implemented the TIMI, FRISC or
HEART score. Hospitals choosing for the latter preferred
a tool that was suitable for a broader category of patients
i.e. patients presenting with chest pain to the emergency
department.Unintended and intended benefits and risks
Participants mentioned that implementing a cardiac risk
score instrument improved uniformity in treating UA
and NSTEMI patients. As a result, participants believed
risk scores enhanced patient safety and efficient resource
use. Moreover, cardiac risk score use led to a more rapid
recognition of high risk patients and created awareness
regarding the appropriate site of care. Among interns,
cardiac risk scores provided a more clear understanding
of the departments’ standards regarding the care for UA
and NSTEMI patients and increased their awareness of
the factors associated with a high risk of adverse cardiac
events. Also, its use gave hospitals the opportunity to
study illness severity among their population of patients.
Participants indicated that the risk score instrument was
used as an objective support system to quantify their risk
assessment, to confirm their assumptions regarding a
patient’s risk and/or to justify their chosen treatment
plan. Possible risks associated with cardiac risk score use
were related to overregulation of the process of care e.g.
because participants indicated that mortality risk may be
overestimated. Therefore, they believed that treatment
policies should not be solely based on a risk score.
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Participants reported variation in the degree cardiac risk
scores affected the choice between the treatment options.
Some participants continued to use conventional risk
stratification and clinical experience solely. Others used
the risk score as a guide in their decision making,
combined with conventional risk stratifiers. In the latter
case, cardiac risk scores were mainly used to identify high
risk patients who would benefit most from aggressive and
timely treatment. In patients with high age, severe heart
failure, cognitive impairments and immobility, physicians
often deviated from the guidelines as cardiac risk scores
could not comprehend the full spectrum of UA or
NSTEMI presentations. A few participants mentioned that
the risk score also influenced their admission protocol
and patient flow. Participants described adjustments in
their admission protocols according to the calculated risk
score outcome, for instance low risk patients were either
sent home, treated at the outpatient department or admit-
ted to the hospital. Cardiac risk scores were also used to
guide patient admission to appropriate sites of care or to
enhance the throughput of patients on the emergency
department.
Effects on process of care
The implementation of cardiac risk scores resulted in most
hospitals in a more uniform approach in supervising interns
and in the assignment of (invasive) treatments, though this
was disputed by a few participants. They questioned
whether hospitals would continue to use cardiac risk scores
in daily practice if the national quality improvement pro-
gram stopped. Actually, a division was observed between
hospital departments which implemented a risk score for
registration purposes solely, and hospitals in which the
guideline recommendations were strictly followed.
Discussion
This study investigated perceptions of health care
professionals concerning the implementation and use of
cardiac risk scores in the management of patients diag-
nosed with UA or NSTEMI.
It appeared that the active involvement of staff mem-
bers, and the presence of champions responsible for data
feedback, sending clinical reminders, education of col-
leagues and promoting cardiac risk score use on their
department were strategies used to implement cardiac risk
scores. These were also found in previous studies regard-
ing the evaluation of guideline implementation in cardi-
ology [31,41,42], or guideline dissemination in general
[37,43]. In implementing cardiac risk scores, two crucial
factors in sustaining their use were mentioned i.e. IT sup-
port arranged and prioritized by the hospital board and
emphasizing the clinical relevance of the risk score. Apart
from the frequent rotation of medical interns, similarbarriers in guideline implementation have been reported
previously [18,44]. In most hospitals the frequent rotation
of medical interns resulted in periodic knowledge deficits
which hindered efforts to sustain cardiac risk score use.
Previous research regarding underperformance of medical
interns or residents identified, among other things, a lack of
medical knowledge and poor decision making and clinical
judgment skills as underlying problems of underperform-
ance [45,46]. This emphasizes the importance of constant
education and feedback in sustaining cardiac risk score use
in clinical practice. It is recommended that future quality
improvement initiatives take the aforementioned barriers
and strategies into account when aiming to improve cardiac
risk score use in clinical practice. In addition, future
updates of the ESC guidelines could emphasize effective
strategies to facilitate cardiac risk score implementation.
However, further research is needed to assess the impact of
the suggested strategies on risk score adherence.
The results in this study further show that in clinical
practice cardiac risk scores were often used as intended,
though the impact of the resulting scores on treatment de-
cisions varied and depended highly on the patient’s risk of
adverse cardiac outcomes. This is in accordance with the
European Society of Cardiology guidelines, which recom-
mend to administer therapies tailored to a patient’s level
of risk [5]. However, it has been reported previously that
beliefs about practice and actual practice differ substan-
tially [41]. It is therefore unknown to what degree cardiac
risk scores affect clinical decision-making in relation to
other information such as electrocardiogram findings or
the presence of co-morbidities. This should be studied
further. Apart from the risk score’s influence on treatment
practices, the scoring instruments also functioned as
objective support systems in quantifying, confirming and/
or justifying physicians’ initial risk assessment. Additional
benefits, included improved uniformity in treatment prac-
tices, educational support and scientific support. These
benefits were in concordance with intrinsic motivations of
participants prior to risk score implementation. In
addition, practitioners who felt forced to use cardiac risk
scores were less likely to take into account the cardiac risk
score in their treatment decisions or saw a benefit of car-
diac risk score use in their own practice, and continued to
use conventional risk stratification and base decision mak-
ing on clinical experience solely. It is therefore recom-
mended for hospital management staff to emphasize and
disperse information about these potential benefits of
using risk scores throughout their organization.
Limitations
In interpreting the results of this study, several limita-
tions should be taken into account. First, to structure
the contents of the interviews, the dimensions of the
Pettigrew and Whipp framework were slightly deviated
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ough analysis of practices in each hospital. Second, the
length of interviews differed considerably between re-
spondents that may have influenced the quality of the
data. It appeared that knowledge regarding the imple-
mentation of cardiac risk scores differed substantially
between participants. Also, some interviews were inter-
rupted because of acute patient admissions. Of these,
memo’s and transcripts were critically reviewed. Where
deemed necessary, follow-up interviews were planned.
Finally, participant checks to enhance external validity
were not conducted (except in case the interview was
not audio-taped), among other things, because of the
likelihood that participants changed their views over
time. The information that emerged from the interviews
may therefore not be representative for all practitioners
involved in the management of patients diagnosed with
UA or NSTEMI, and may differ for hospitals not in-
volved in the study. However, we presume these differ-
ences to be negligible due to the diversity in participant
characteristics and because saturation was obtained. In
addition, it was assumed that audio-taping of the inter-
views and transcribing verbatim contributed in great ex-
tent to the validity of the study results. Also, the use of
risk scores is embedded in several international cardiac
guidelines. In the Netherlands, it is strongly recom-
mended to use the European Society of Cardiology
guidelines in the management of UA and NSTEMI pa-
tients. The results of this study could therefore be of use
for all practitioners applying these guidelines in the
management of UA or NSTEMI patients as the context
of care is comparable.Conclusions
Health care practitioners disagree on the importance of
cardiac risk scores used to decide on the management
of unstable angina or non-ST-elevation myocardial
infarction patients. Practitioners predominantly experi-
enced benefits in policy-making, education and research
when intrinsic motivations were underlying the imple-
mentation of cardiac risk scores. In addition, practi-
tioners who felt forced to use cardiac risk scores were
less likely to take into account the cardiac risk score in
their treatment decisions. The study results can be used
to develop effective strategies that stimulate or sustain
cardiac risk score use in future practice and reduce
practice variation in the management of UA and
NSTEMI patients. These strategies may be incorporated
in future updates of the ESC guidelines, as currently
these do not contain information on how to implement
cardiac risk scores in clinical practice. However, several
barriers that affect implementation and applicability in
practice need to be taken into account.Additional files
Additional file 1: Key informant interview guide. Key informant
interview guide based on the WHY/HOW/WHAT dimensions of the
Pettigrew and Whipp framework for strategic change and existing
implementation literature.
Additional file 2: Table S3. Representative quotations. Illustrating
quotations of interviewees.
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